SCHEMBL7464170

SCHEMBL7464170

COc1ccc(F)c(/C=C2/SC(=O)NC2=O)c1-c1cc2c(cc1C)C(C)(C)CCC2(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 3/20 0.47
PIM2 Q9P1W9 3/20 0.47
PDE4B Q07343 2/20 0.47
PIM3 Q86V86 2/20 0.47
GSK3B P49841 3/20 0.44
IGF1R P08069 3/20 0.42
AKR1B1 P15121 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
PTPN1 P18031 2/20 0.42
CDC7 O00311 1/20 0.42
DAPK3 O43293 1/20 0.42
DYRK3 O43781 1/20 0.42
MAP4K4 O95819 1/20 0.42
PHKG2 P15735 1/20 0.42
RPS6KB1 P23443 1/20 0.42
CSNK1D P48730 1/20 0.42
CLK2 P49760 1/20 0.42
GSK3A P49840 1/20 0.42
NEK4 P51957 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7464177 1.00 PIM1 (0.47) PIM1PIM2PDE4BPIM3GSK3B
SCHEMBL14492729 0.86 PTPN1 (0.42) PIM1PIM2PDE4BPIM3GSK3B
SCHEMBL5488084 0.86 PTPN1 (0.42) PIM1PIM2PDE4BPIM3GSK3B
SCHEMBL5488085 0.86 PTPN1 (0.42) PIM1PIM2PDE4BPIM3GSK3B
SCHEMBL5488144 0.86 PTPN1 (0.48) PIM1PIM2PDE4BPIM3GSK3B
SCHEMBL14492585 0.86 PTPN1 (0.48) PIM1PIM2PDE4BPIM3GSK3B
SCHEMBL5488140 0.86 PTPN1 (0.48) PIM1PIM2PDE4BPIM3GSK3B
SCHEMBL7469497 0.83 IGF1R (0.52) PIM1PIM2PDE4BPIM3GSK3B
SCHEMBL7469493 0.83 IGF1R (0.52) PIM1PIM2PDE4BPIM3GSK3B
SCHEMBL7467691 0.83 GSK3B (0.46) PIM1PIM2PDE4BPIM3GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214305-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION Maxia Pharmaceuticals, Inc. (US) 2002-06-19 EP disclosed
WO-2001016123-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION MAXIA PHARMACEUTICALS, INC. (US) 2001-03-08 WO disclosed